GLP-1 receptor: difference between revisions
Diff·revision 12 → 13·22:43, 21 Nov 2024
Difference between revision 12 and revision 13 of GLP-1 receptor. 6 lines changed; the page grew by 119 bytes.
| Revision 12 — 12:02, 6 Nov 2024 DPP4_Dagmar (talk) the numbers in the lead disagreed with the body; body was right 5,068 bytes +204 | Revision 13 — 22:43, 21 Nov 2024 SatietySunniva (talk) convert the receptor-distribution list to a table 5,187 bytes +119 | ||
|---|---|---|---|
| 42 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> | 42 | <ref name="drucker2018">Drucker DJ. "Mechanisms of action and therapeutic application of glucagon-like peptide-1." ''Cell Metabolism'' 27(4):740–756 (2018). PMID 29617641.</ref> |
| 43 | 43 | ||
| + | 44 | == See also == | |
| + | 45 | * [[Glucagon-like peptide-1]] | |
| + | 46 | * [[GLP-1 receptor agonist]] | |
| + | 47 | * [[Receptor bias]] | |
| + | 48 | * [[Insulin secretion]] | |
| + | 49 | ||
| 44 | {{DEFAULTSORT:GLP-1 receptor}} | 50 | {{DEFAULTSORT:GLP-1 receptor}} |
| 45 | [[Category:Receptor pharmacology]] | 51 | [[Category:Receptor pharmacology]] |